Skip to main content
JSW Dulux Limited logo

JSW Dulux Limited — Investor Relations & Filings

Ticker · JSWDULUX ISIN · INE133A01011 BSE.NS Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2026-01-28 Regulatory Filings
Country IN India
Listing BSE.NS JSWDULUX

About JSW Dulux Limited

https://www.jswpaints.in/

JSW Dulux Limited specializes in the development, manufacture, and distribution of a comprehensive range of decorative and industrial coating solutions. The company’s portfolio includes interior and exterior emulsions, protective finishes, enamels, and specialized wood coatings designed for both residential and commercial applications. Utilizing advanced chemical formulations, the organization focuses on delivering high-performance products characterized by durability, color precision, and environmental sustainability. Key offerings feature low-VOC compositions, weather-resistant technologies, and anti-microbial properties. The company serves a broad market spectrum, providing technical coating systems for infrastructure projects alongside consumer-grade paints. Its operations emphasize innovation in surface protection and aesthetic enhancement through rigorous research and development.

Recent filings

Filing Released Lang Actions
Please find attached intimation of group investor call scheduled on 3rd February 2026 at 3pm.
Regulatory Filings Classification · 95% confidence The document is a notification from Akzo Nobel India Limited about an upcoming group conference call to discuss the financial results for the quarter and nine months ended 31st December 2025. It includes details about the date, time, and participants of the call, as well as contact information. The document does not contain the actual financial results or detailed financial statements, but rather serves as an announcement of the conference call where such results will be discussed. The document length is short (2593 characters), and it is clearly an invitation to a call rather than the call transcript itself or the financial report. Therefore, the appropriate classification is a Call Transcript (CT) if it were the transcript, but since this is an invitation to the call, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the call. However, given the options, the closest specific category is Call Transcript (CT) because it relates directly to the conference call about earnings, but since it is only an invitation and not the transcript, the fallback Regulatory Filings (RNS) is more appropriate. Hence, the document is best classified as Regulatory Filings (RNS) with high confidence.
2026-01-28 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter from Akzo Nobel India Limited to stock exchanges providing a monthly update on the re-lodgement of transfer requests of physical shares, pursuant to a SEBI circular. It includes a report from the Registrar and Transfer Agent (RTA) confirming the status of requests received, processed, approved, and rejected for the period ended December 31, 2025. The document is short (2762 characters) and serves as an update or notification rather than a full financial or operational report. It does not contain financial statements, management discussion, or detailed analysis. It is an official regulatory update related to share transfer requests compliance with SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2026-01-14 English
Please find attached status report for the month of December 2025 pertaining to relodgement of transfer requests of physical shares.
Regulatory Filings Classification · 95% confidence The document is a letter from Akzo Nobel India Limited to stock exchanges providing a monthly update on the re-lodgement of transfer requests of physical shares, pursuant to a SEBI circular. It includes a report from the Registrar and Transfer Agent (RTA) confirming the status of requests received, processed, approved, and rejected for the period ended December 31, 2025. The document is short (2762 characters) and serves as an update or notification rather than a full financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is an official regulatory update related to share transfer requests compliance with SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2026-01-14 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-09 English
Please find attached disclosure under regulation 30 towards change in directors viz. Appointment of Mr Shantanu Maharaj Khosla as Independent Director, Redesignation of Mr Rajiv Rajgopal ....
Board/Management Information Classification · 100% confidence The document is a formal communication from Akzo Nobel India Limited dated 9th January 2026 addressed to stock exchanges (BSE and NSE). It announces changes in the Board of Directors, including appointments and re-designations of directors, with detailed profiles and regulatory compliance disclosures. The content focuses exclusively on board changes and related regulatory disclosures under SEBI regulations. There is no financial data, earnings information, or report publication mentioned. The document is not a report itself but an announcement of board/management changes. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length (11,813 characters) supports it being a full announcement rather than a brief notice or certification.
2026-01-09 English
Please find attached the outcome of board meeting held on 9th January 2026
Board/Management Information Classification · 95% confidence The document is a formal communication from Akzo Nobel India Limited dated 9th January 2026 addressed to stock exchanges (BSE and NSE). It announces changes in the company's board of directors, including appointments and re-designations of directors and the chairman. The document includes detailed profiles of the new appointees and disclosures required under SEBI regulations. There is no financial data, earnings information, or report publication mentioned. The primary content is about changes in the company's board and senior management positions. Therefore, this document fits the category of Board/Management Information (MANG). The document length (11,813 characters) and detailed content support this classification with high confidence.
2026-01-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.